Published on
The deadly Candida auris fungus was first identified in the United States about 10 years ago and has proven to have strong drug-resistance, at times demonstrating resistance to all 3 main classes of antifungal medicines, including echinocandins. And cases appear to be on the rise. Of the 1,052 cases reported to the Centers for Disease Control and Prevention through April 26, 2025, a disproportionate number are occurring in Texas (241), Michigan (185), and Ohio (125). Candida auris can cause skin and bloodstream infections and mainly spreads in healthcare settings. It can survive on surfaces, causing risk of further spread. As many as 60% of people with Candida auris infections have died, but most had other underlying conditions.
What to look for: According to CDC, there is not a common set of symptoms specific for Candida auris. Symptoms may be similar to other infections caused by bacteria, including fever or chills. CDC offers prevention recommendations on its website.